Financial Architects, Inc Guardant Health, Inc. Transaction History

Financial Architects, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$80.32 - $111.8 $16,063 - $22,360	-200 Closed	0 $0
Q1 2020 May 07, 2020	SELL	$59.04 - $88.81 $120,146 - $180,728	-2,035 Reduced 91.05%	200 $14,000
Q4 2019 Feb 14, 2020	BUY	$59.49 - $82.78 $126,297 - $175,741	2,123 Added 1895.54%	2,235 $175,000
Q1 2019 May 03, 2019	BUY	$34.3 - $97.98 $3,841 - $10,973	112 New	112 $9,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.17B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.